特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
969252

セルベースアッセイおよびハイコンテントスクリーニング市場:用途別の予測(2021年~2025年)

Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2021 to 2025

出版日: | 発行: Howe Sound Research | ページ情報: 英文 250 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
セルベースアッセイおよびハイコンテントスクリーニング市場:用途別の予測(2021年~2025年)
出版日: 2020年11月05日
発行: Howe Sound Research
ページ情報: 英文 250 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

セルベースアッセイは医薬品開発と科学研究の主役ですが、COVID-19治療の競争加速に伴い、セルベースアッセイおよびハイコンテントスクリーニング市場は急成長しており、同市場は今後も継続的な成長が見込まれています。

当レポートは、世界のセルベースアッセイおよびハイコンテントスクリーニング市場について調査しており、市場規模、成長および抑制要因、技術開発、ユーザータイプ・製品クラス・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

マーケットガイド

  • 状況分析とCOVID-19の影響
  • エグゼクティブおよびマーケティングスタッフのためのガイド
  • 投資アナリストおよび経営コンサルタントのためのガイド

第1章 イントロダクションと市場の定義

  • セルベースアッセイとは何か?
  • 臨床試験の失敗
  • 市場の定義
  • 調査手法
  • 米国の医療市場と医薬品調査支出:展望

第2章 セルベースアッセイのテクノロジーガイド

  • 細胞培養
  • 細胞アッセイ
  • 細胞生存アッセイ
  • 細胞増殖アッセイ
  • 細胞毒性アッセイ
  • 細胞老化アッセイ
  • アポトーシス
  • オートファジー
  • 壊死
  • 酸化ストレス
  • 2Dと3D
  • シグナル伝達経路、GPCR
  • 免疫調節と抑制
  • レポーター遺伝子工学
  • CBAの設計と開発
  • セルベースのアッセイ-要点

第3章 業界の概要

  • 市場参入企業
    • 学術調査室
    • 受託調査機関
    • ゲノム計装サプライヤー
    • 細胞株および試薬サプライヤー
    • 製薬企業
    • 監査機関
    • 認証機関

第4章 市場動向

  • 成長要因
    • 候補の成長
    • 免疫腫瘍学
    • ゲノムブリザード
    • テクノロジーコンバージェンス
    • 保険効果
  • 抑制要因
    • CBA開発の課題
    • 機器の統合
    • プロトコル
  • 技術開発
    • 3Dアッセイ
    • オートメーション
    • ソフトウェア
    • 一次電池
    • シグナル伝達およびレポーター遺伝子
    • 次の5年間

第5章 セルベースアッセイ最近の開発

  • 最近の開発:重要性とこのセクションの使用方法
    • これらの開発の重要性
    • このセクションの使用方法
      • AxxamとFUJIFILMCellularDynamicsが戦略的提携を発表
      • CuriBioが人工知能企業のDana Solutionsを買収
      • CRISPRスクリーンにより明らかになる新たな癌治療標的
      • ERSGenomicsがCRISPR-Cas9特許をAxxamにライセンス供与
      • 化合物のスクリーニングを容易にする新しいトランスクリプトミクスアッセイ
      • ハイスループット抗がん剤候補を特定
      • Charles River LaboratoriesがCitoxlabを買収
      • Reaction BiologyCorporationがProQinaseGmbHを買収、など

第6章 主要企業のプロファイル

  • Abcam
  • Agilent
  • Aurora Instruments Ltd.
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • BMG Labtech
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Horizon Discovery
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • Perkin Elmer
  • Promega
  • Qiagen Gmbh
  • Reaction Biology
  • Recursion Pharma
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

第7章 世界の市場規模

  • 国別の世界の市場概要
  • ユーザー別の世界の市場-概要
  • 製品クラス別の世界の市場-概要

第8章 ユーザータイプ別の世界市場

  • 製薬
  • 調査
  • 産業/化粧品

第9章 製品クラス別のセルベースアッセイ

  • 機器
  • 試薬
  • サービス
  • ソフトウェア

第10章 付録

  • 年ごとのFDAがん治療薬の承認
  • 2010年から2016年に開始された臨床試験
  • 国別の製薬研究開発のシェア
図表

Table of Tables

  • Table 1 The Large Variety of Cell Lines
  • Table 2 Some Common Viability Assays
  • Table 3 Oxidative Stress Related Diseases
  • Table 4 Important Signalling Pathways
  • Table 5 Market Players by Type
  • Table 6 Five Factors Driving Growth
  • Table 7 Three Factors Limiting Growth
  • Table 8 - Global Market by Region
  • Table 9 Global Market by User
  • Table 10 Global Market by Product Class
  • Table 11 Pharma by Country
  • Table 12 Research by Country
  • Table 13 Industry/Cosmetic by Country
  • Table 14 Instrument by Country
  • Table 15 Reagent by Country
  • Table 16 Services by Country
  • Table 17 Software by Country

Table of Figures

  • Figure 1 Reasons for clinical Failure by Phase
  • Figure 2 Immunotherapy Clinical Trial Growth
  • Figure 3 Pharmaceutical Research Expenditures 2001 to 2017 ($Billion)
  • Figure 4 Oxidative Stress and Free Radical Toxicity
  • Figure 5 FDA Cancer Drug Approvals
  • Figure 6 Growth rates of Cell Based Assays by Product Class
  • Figure 7 Global Market Share Chart
  • Figure 8 Global Market by User - Base vs. End Year
  • Figure 9 Global Market by User Base Year
  • Figure 10 Global Market by User End Year
  • Figure 11 User Share by Year
  • Figure 12 Global Market by Product Class - Base vs. End Year
  • Figure 13 Global Market by Product Class Base Year
  • Figure 14 Global Market by Product Class End Year
  • Figure 15 Product Class Share by Year
  • Figure 16 Pharma Growth
  • Figure 17 Research Growth
  • Figure 18 Industry/Cosmetic Growth
  • Figure 19 Instrument Growth
  • Figure 20 Reagent Growth
  • Figure 21 Services Growth
  • Figure 22 Software Growth
  • Figure 23 FDA Cancer Drug Approvals by Year
  • Figure 24 Clinical Trials for Immunotherapy by Year
  • Figure 25 Share of Pharma R&D by Country
目次

Cell Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as the race for a COVID-19 cure gains speed. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell is a member of The American Association for Clinical Chemistry. Mr. Powell's education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research Seminar - Burke Institute

Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis & COVID-19 Impact
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What are Cell Based Assays?
  • 1.2 Clinical Trial Failures
    • 1.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
    • 1.2.2 Infectious Disease Will Play a Larger Role
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and Pharmceutical Research Spending - Perspective
    • 1.5.1 U.S. Expenditures for Pharmaceutical Research

2. Cell Based Assays - Guide to Technology

  • 2.1 Cell Cultures
    • 2.1.1 Cell Lines
    • 2.1.2 Primary Cells
    • 2.1.3 Stem Cells
      • 2.1.3.1 iPSC's - The Special Case
  • 2.2 Cell Assays
  • 2.3 Cell Viability Assays
  • 2.3 Cell Proliferation Assays
  • 2.4 Cytotoxicity Assays
  • 2.5 Cell Senescence Assays
  • 2.6 Apoptosis
  • 2.7 Autophagy
  • 2.8 Necrosis
  • 2.9 Oxidative Stress
  • 2.10 2D vs. 3D
  • 2.11 Signalling Pathways, GPCR
  • 2.12 Immune Regulation & Inhibition
  • 2.13 Reporter Gene Technology
  • 2.14 CBA Design & Development
  • 2.15 Cell Based Assays - The Takeaway

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Contract Research Organization
    • 3.1.3 Genomic Instrumentation Supplier
    • 3.1.5 Cell Line and Reagent Supplier
    • 3.1.6 Pharmaceutical Company
    • 3.1.7 Audit Body
    • 3.1.8 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Candidate Growth
    • 4.1.2 Immuno-oncology
    • 4.1.3 Genomic Blizzard
    • 4.1.4 Technology Convergence
    • 4.1.5 The Insurance Effect
  • 4.2 Factors Limiting Growth
    • 4.2.1 CBA Development Challenges
    • 4.2.2 Instrument Integration
    • 4.2.3 Protocols
  • 4.3 Technology Development
    • 4.3.1 3D Assays
    • 4.3.2 Automation
    • 4.3.3 Software
    • 4.3.4 Primary Cells
    • 4.3.5 Signalling and Reporter Genes
    • 4.3.6 The Next Five Years

5. Cell Based Assays Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
      • Cancer Genetics to Acquire Organoid Startup Stemonix
      • Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
      • CRISPR Screens Uncover Novel Cancer Therapy Targets
      • ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam
      • New Transcriptomics Assay Facilitates Compound Screens
      • Carta Biosciences Betting on Gene Interaction Mapping
      • High-throughput Identifies cancer drug candidates
      • Velabs Therapeutics partners with Alytas Therapeutics to develop a novel immune-based therapy for obesity
      • InSphero platform selected to test Cyclerion's sGC stimulator technology
      • OcellO to provide in vitro research services to Merus
      • Charles River Laboratories to acquire Citoxlab
      • Reaction Biology Corporation Purchases ProQinase GmbH
      • Cisbio extends its assay portfolio for immuno-oncology drug discovery
      • STEMCELL Technologies Launches Next-Generation Culture System
      • Abcam Acquires Calico Biolabs
      • Evotec announces achievement in Celgene alliance utilizing IPSC screening
      • Fujifilm Cellular Dynamics Inc. launches iCELL Microglia
      • Cisbio and Excellerate Bioscience partner
      • Horizon Discovery extends CRISPR Screening Service to primary human T cells

6. Profiles of Key Cell Based Assay Companies

  • Abcam
  • Agilent
  • Aurora Instruments Ltd.
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • BMG Labtech
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Horizon Discovery
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • Perkin Elmer
  • Promega
  • Qiagen Gmbh
  • Reaction Biology
  • Recursion Pharma
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

7. Global Market Size

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country
  • 7.2 Global Market by User - Overview
    • 7.2.1 Table - Global Market by User
    • 7.2.2 Chart - Global Market by User - Base/End Year Comparison
    • 7.2.3 Chart - Global Market by User - Base Year
    • 7.2.4 Chart - Global Market by User - End Year
    • 7.2.5 Chart - Global Market by User - Share by Year
  • 7.3 Global Market by Product Class - Overview
    • 7.3.1 Table - Global Market by Product Class
    • 7.3.2 Chart - Global Market by Product Class - Base/End Year Comparison
    • 7.3.3 Chart - Global Market by Product Class - Base Year
    • 7.3.4 Chart - Global Market by Product Class - End Year
    • 7.3.5 Chart - Global Market by Product Class - Share by Year

8. Global Market by User Type

  • 8.1 Pharma
    • 8.1.1 Table Pharma - by Country
    • 8.1.2 Chart - Pharma Growth
  • 8.2 Research
    • 8.2.1 Table Research - by Country
    • 8.2.2 Chart - Research Growth
  • 8.3 Industry/Cosmetic
    • 8.3.1 Table Industry/Cosmetic - by Country
    • 8.3.2 Chart - Industry/Cosmetic Growth

9. Cell Based Assay by Product Class

  • 9.1 Instrument
    • 9.1.1 Table Instrument - by Country
    • 9.1.2 Chart - Instrument Growth
  • 9.2 Reagent
    • 9.2.1 Table Reagent - by Country
    • 9.2.2 Chart - Reagent Growth
  • 9.3 Services
    • 9.3.1 Table Services - by Country
    • 9.3.2 Chart - Services Growth
  • 9.4 Software
    • 9.4.1 Table Software - by Country
    • 9.4.2 Chart - Software Growth

10. Appendices

  • 10.1 FDA Cancer Drug Approvals by Year
  • 10.2 Clinical Trials Started 2010 to 2016
  • 10.3 Share of Pharma R&D by Country
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.